The seminal evidence that placed PPARα at the center of lipoprotein metabolismwas the demonstration that fibrates, which had been used clinically for many years to treat dyslipidemia, act by binding to PPARα andinduce PPARα-dependent gene transcription [4, 14]. Here, PPARA is linked to metabolic syndrome.